Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Equity

Aditya Birla Sun Life Mutual Fund

Sector - Healthcare

Get the latest NAV of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.

₹32.59

▼-0.3%1D

NAV as on 16 May 2025

22.28%/per year

Since Inception

Absolute Gain%

▲▼

984 people have invested ₹ 44.6L in Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth in the last three months

Aditya Birla Sun Life Pharma & Healthcare Fund Performance vs. Nifty 500

Fund returns vs Benchmark returns vs Category Average returns as on (16-May-25)

The fund has outperformed the benchmark (Nifty 500) over 1Y, 3Y, but underperformed over 5Y.

Period
This Fund
Nifty 500
Category Avg
1 Month
1.94%
5.49%
3.03%
3 Months
5.71%
10.74%
5.82%
6 Months
-0.46%
4.13%
-0.22%
1 Year
13.51%
8.58%
18.45%
3 Years
22.98%
17.98%
22.89%
5 Years
21.66%
24.97%
22.54%

INDmoney Rank

Powered by IND quant engine

IND ranking is not available for this fund.

Fund Name
INDmoney Rank
AUM (in Crs.)
Expense Ratio
1Y Returns
3Y Returns
Inception Returns
Aditya Birla Sun Life Pharma & Healthcare Fund
8/8
818Cr
1.05%
13.51%
22.98%
22.28%
SBI Healthcare Opportunities Fund Direct Growth
1/8
3,671Cr
0.9%
21.69%
28.53%
18.19%
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
3/8
5,295Cr
1.11%
24.36%
28.66%
22.71%
DSP Healthcare Fund Direct Growth
4/8
2,912Cr
0.63%
14.42%
24.43%
24.21%
See all
Positive: Beats FD returns for both 3Y & 5Y duration
Beats FD returns for both 3Y & 5Y duration
Negative: 5Y returns in the bottom 25% of the category
5Y returns in the bottom 25% of the category
Negative: 3Y returns in the bottom 25% of the category
3Y returns in the bottom 25% of the category

Aditya Birla Sun Life Pharma & Healthcare Fund Returns Calculator

Calculate SIP and lumpsum returns based on historical performance

  • 1-time

  • SIP

Total Investment

0

Profit

Total Corpus

0

Absolute Return
▲
▼

Aditya Birla Sun Life Pharma & Healthcare Fund Asset Allocation

See fund asset allocation details as on (13-May-25)

Fund Distribution

as on (13-May-25)

Equity 98.2%

Debt & Cash 1.8%

Mid cap
44.5%
Large cap
31.4%
Small cap
22.3%
Mid Cap allocation has gone up from 43.3% to 44.5%
Mid Cap allocation has gone up from 43.3% to 44.5%
Large Cap allocation has gone down from 32.5% to 31.4%
Large Cap allocation has gone down from 32.5% to 31.4%
Small Cap allocation has gone down from 22.9% to 22.3%
Small Cap allocation has gone down from 22.9% to 22.3%
Cash allocation has gone up from 1.2% to 1.8%
Cash allocation has gone up from 1.2% to 1.8%

Aditya Birla Sun Life Pharma & Healthcare Fund Sector Allocation

See fund sector allocation details as on (13-May-25)

Sector Allocation

Equity 98.2%

Debt & Cash 1.8%

Health
97.6%
Financial Services
1.5%
Basic Materials
0.9%

Top 2 Sectors in April were Health, Basic Materials

Apr'25

Health

99%

Basic Materials

Mar'25

Health

99%

Basic Materials

Aditya Birla Sun Life Pharma & Healthcare Fund Holdings Details

as on (30-Apr-25)

Equity

Top Stocks bought last month
Sun Pharmaceuticals Industries Ltd's allocation increased from 14.61% to 15.37%
Sun Pharmaceuticals Industries Ltd's allocation increased from 14.61% to 15.37%
Apollo Hospitals Enterprise Ltd's allocation increased from 6.9% to 7.24%
Apollo Hospitals Enterprise Ltd's allocation increased from 6.9% to 7.24%
Aurobindo Pharma Ltd's allocation increased from 4.86% to 5.13%
Aurobindo Pharma Ltd's allocation increased from 4.86% to 5.13%
Top Stocks sold last month
Cipla Ltd's allocation decreased from 8.44 % to 8.09 %
Cipla Ltd's allocation decreased from 8.44 % to 8.09 %
Torrent Pharmaceuticals Ltd's allocation decreased from 7.05 % to 6.49 %
Torrent Pharmaceuticals Ltd's allocation decreased from 7.05 % to 6.49 %
Abbott India Ltd's allocation decreased from 6.14 % to 5.97 %
Abbott India Ltd's allocation decreased from 6.14 % to 5.97 %

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Overview

Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.

Expense ratio1.05%
Benchmark
BSE Healthcare TR INR
AUM₹818 Cr
Inception Date11 July, 2019
Min Lumpsum/SIP₹1000/₹100
Exit Load
1.0%
Lock InNo Lock-in
TurnOver
33.35%
STCGSelling mutual fund before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

About Aditya Birla Sun Life Pharma & Healthcare Fund

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is an equity fund. This fund was started on 11 July, 2019. The fund is managed by Dhaval Shah. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth has ₹818 Cr worth of assets under management (AUM) as on Apr 2025 and is less than category average.
  2. The fund has an expense ratio 1.1.

Returns

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth has given a CAGR return of 22.28% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 13.51%, 22.98% and 21.66% respectively.

Holdings

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Apollo Hospitals Enterprise Ltd, Torrent Pharmaceuticals Ltd, Abbott India Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 1000.00 and for SIP is INR 100.00. Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth has no lock in period.

Fund Manager

Dhaval Shah

Fund Manager of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth, since 11 July 2019

Learn more about Aditya Birla Sun Life Mutual Fund
Parameters
Apr'25
Mar'25
Feb'25
AUM
₹ 818.3 Cr
₹ 814.9 Cr
₹ 754.8 Cr
  • AUM of the fund stands at 818.3 Cr as of Apr'25
  • AUM increased by 3.4 Cr between Apr'25 and Mar'25

Compare Aditya Birla Sun Life Pharma & Healthcare Fund

Aditya Birla Sun Life Pharma & Healthcare Fund

VS

Nippon India Pharma Fund Direct Growth

Frequently Asked Questions for Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

What is the current NAV of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth?

The current NAV of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is ₹32.59 as on 16-May-2025.

What are the average returns of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth?

Existing (Absolute + CAGR) as on 16-May-2025.
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
1.94%
1.94%
6 Month Returns
-0.46%
-0.46%
1 Year Returns
13.51%
13.51%
3 Years Returns
86.02%
22.98%

How do I invest in Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth?

With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.

What is the expense ratio of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth?

1.05% as on April 2025

What is net assets under management (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth?

₹818 Cr as on April 2025

What are the top 5 holdings of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth?

Sun Pharmaceuticals Industries Ltd(15.37%), Cipla Ltd(8.09%), Apollo Hospitals Enterprise Ltd(7.24%), Torrent Pharmaceuticals Ltd(6.49%), Abbott India Ltd(5.97%) as on April 2025

What is the alpha of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth?

The alpha ratio for the Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
-2.76
-
-0.56
As on April 2025
The alpha for Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is calculated against BSE Healthcare TR INR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.

What is the beta of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth??

The Beta ratio for the Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
0.95
0.95
0.94
As on April 2025
The Beta for Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is calculated with BSE Healthcare TR INR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.

What is the sharpe ratio of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth?

The sharpe ratio for the Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
0.51
0.8
0.96
As on April 2025
The sharpe ratio for Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is calculated with BSE Healthcare TR INR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.

What is the standard deviation of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth?

The standard deviation for the Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
19.7
16.81
16.18
As on April 2025
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.

What is the Sortino ratio of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth?

Sortino ratio is 1.42 as on April 2025. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.

Who is the manager of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth?

Dhaval Shah is the fund manager of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

What is the exit load of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth?

The Exit load of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is 1%